日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Candidate Bevacizumab Biosimilar CT-P16 versus European Union Reference Bevacizumab in Patients with Metastatic or Recurrent Non-Small Cell Lung Cancer: A Randomized Controlled Trial

候选贝伐单抗生物类似药CT-P16与欧盟参考贝伐单抗治疗转移性或复发性非小细胞肺癌患者的随机对照试验

Verschraegen, Claire; Andric, Zoran; Moiseenko, Fedor; Makharadze, Tamta; Shevnya, Sergii; Oleksiienko, Alona; Yañez Ruiz, Eduardo; Kim, SungHyun; Ahn, KeumYoung; Park, TaeHong; Park, Sijin; Ju, Hana; Ohe, Yuichiro